Cathie Wood ARK Investment Management
Cathie Wood is the founder, CEO, and CIO of ARK Investment Management, an investment firm known for its focus on “disruptive innovation”. She gained widespread attention for her bold market calls and high conviction in cutting-edge technologies such as electric vehicles, genomics, and blockchain. Under her guidance, ARK’s exchange-traded funds (ETFs) attracted substantial interest from both retail and institutional investors. Wood’s investment philosophy emphasizes research-driven analysis and long-term growth potential, positioning her as one of today’s most influential voices in the world of finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$79.3M |
| 2 |
Roblox
RBLX
|
+$54.1M |
| 3 |
ARK 21Shares Bitcoin ETF
ARKB
|
+$33.2M |
| 4 |
Recursion Pharmaceuticals
RXRX
|
+$31M |
| 5 |
Shopify
SHOP
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$234M |
| 2 |
Coinbase
COIN
|
+$198M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$161M |
| 4 |
Robinhood
HOOD
|
+$138M |
| 5 |
Ginkgo Bioworks
DNA
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Healthcare | 24.46% |
| 3 | Communication Services | 18.33% |
| 4 | Consumer Discretionary | 12.38% |
| 5 | Financials | 12.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$57.9B
| $125M | 1.11% |
1,054,094
-163,289
| -13% | -$20.7M |
|
27
SoFi Technologies
SOFI
$24.4B
| $96.1M | 0.85% |
14,535,772
-1,687,427
| -10% | -$11.9M |
|
28
Kratos Defense & Security Solutions
KTOS
$10.7B
| $93.3M | 0.83% |
4,660,808
-846,027
| -15% | -$16.5M |
|
29
Archer Aviation
ACHR
$4.85B
| $89.6M | 0.8% |
25,457,388
-2,801,465
| -10% | -$10.4M |
|
30
CareDx
CDNA
$2.51B
| $88.6M | 0.79% |
5,702,351
-161,695
| -3% | -$1.95M |
|
31
Teladoc Health
TDOC
$1.16B
| $73.2M | 0.65% |
7,481,255
-8,553,415
| -53% | -$104M |
|
32
Iridium Communications
IRDM
$5.19B
| $67.1M | 0.6% |
2,520,547
-52,633
| -2% | -$1.48M |
|
33
Ionis Pharmaceuticals
IONS
$9.93B
| $64.9M | 0.58% |
1,361,025
-38,827
| -3% | -$1.59M |
|
34
Trimble
TRMB
$14B
| $64.1M | 0.57% |
1,147,045
-168,786
| -13% | -$9.74M |
|
35
AeroVironment
AVAV
$8.14B
| $59M | 0.52% |
323,764
-128,436
| -28% | -$23.1M |
|
36
Toast
TOST
$21.2B
| $57.8M | 0.51% |
2,244,344
-380,020
| -14% | -$9.19M |
|
37
NVIDIA
NVDA
$5.2T
| $51.6M | 0.46% |
417,687
-250,733
| -38% | -$25.4M |
|
38
Nurix Therapeutics
NRIX
$2.77B
| $48.5M | 0.43% |
2,323,332
-312,006
| -12% | -$4.86M |
|
39
Arcturus Therapeutics
ARCT
$382M
| $47.8M | 0.42% |
1,964,964
+275,315
| +16% | +$8.35M |
|
40
Schrodinger
SDGR
$1.47B
| $47.3M | 0.42% |
2,447,629
-70,356
| -3% | -$1.62M |
|
41
Pacific Biosciences
PACB
$420M
| $45.5M | 0.4% |
33,212,454
-77,683
| -0.2% | -$157K |
|
42
Natera
NTRA
$47.9B
| $45M | 0.4% |
415,342
+92,958
| +29% | +$9.44M |
|
43
Spotify
SPOT
$110B
| $44.6M | 0.4% |
142,109
-17,884
| -11% | -$5.38M |
|
44
TSMC
TSM
$2.17T
| $44.6M | 0.4% |
256,429
+11,377
| +5% | +$1.73M |
|
45
Mercado Libre
MELI
$97.5B
| $42.8M | 0.38% |
26,037
-12,260
| -32% | -$19.4M |
|
46
Adaptive Biotechnologies
ADPT
$4.15B
| $41.3M | 0.37% |
11,412,000
+850,704
| +8% | +$2.7M |
|
47
CrowdStrike
CRWD
$195B
| $38.5M | 0.34% |
401,732
-58,208
| -13% | -$4.84M |
|
48
Advanced Micro Devices
AMD
$773B
| $38.4M | 0.34% |
236,798
+46,966
| +25% | +$7.56M |
|
49
Vertex Pharmaceuticals
VRTX
$139B
| $35.4M | 0.31% |
75,464
-14,640
| -16% | -$6.35M |
|
50
Cerus
CERS
$566M
| $35M | 0.31% |
19,900,184
-1,645,012
| -8% | -$2.94M |
|
Similar funds
Cathie Wood's Q2 2024 Portfolio in Review
As of Q2 2024, Cathie Wood held 238 positions worth $11.3B, down 22% from $14.4B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Cathie Wood withdrew a net $1.68B in Q2 2024, closing 48 positions and reducing 128 holdings. Its most notable exit was StoneCo, an estimated $11.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Cathie Wood opened a new position in Tempus AI worth $18.3M.
- Cathie Wood's largest Q2 2024 buy was Tempus AI: 522,698 shares worth $18.3M.
- Cathie Wood added most to 10x Genomics in Q2 2024, an estimated $79.3M increase.
- Cathie Wood's biggest Q2 2024 reduction was Zoom, cutting an estimated $234M.
- Cathie Wood fully exited StoneCo in Q2 2024, selling an estimated $11.4M.
- Cathie Wood's ten largest holdings make up 49% of its $11.3B portfolio in Q2 2024.
- Cathie Wood opened 9 new positions and closed 48 in Q2 2024.
- Cathie Wood's portfolio value fell 22% quarter-over-quarter to $11.3B.
Based on ARK Investment Management's 13F filing for Q2 2024, filed 26 Jul 2024.